HSV-1 ICP0: Paving the way for viral replication

Future Virology

Volumn 6, Issue 4, 2011, Pages 421-429

  Smith, Miles C ^a   Boutell, Chris ^b   Davido, David J ^a  

^a UNIVERSITY OF KANSAS   (United States)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

E3 ubiquitin ligase; herpes simplex virus; ICP0; innate immunity; intrinsic defense; nuclear domain 10; viral transactivator

Indexed keywords

INFECTED CELL PROTEIN 0; UBIQUITIN PROTEIN LIGASE E3; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ARTICLE; ENZYME ACTIVITY; GENE EXPRESSION; HERPES SIMPLEX; HERPES SIMPLEX VIRUS 1; HUMAN; LIFE CYCLE; NONHUMAN; PRIORITY JOURNAL; PROTEIN STRUCTURE; VIRUS GENE; VIRUS REPLICATION;

HUMAN HERPESVIRUS 1; SIMPLEXVIRUS;

EID: 79955772653     PISSN: 17460794     EISSN: None     Source Type: Journal    
DOI: 10.2217/fvl.11.24     Document Type: Article

References (91)

1. Cai W, Schaffer PA: Herpes simplex virus type 1 ICP0 regulates expression of immediate-early, early, and late genes in productively infected cells. J. Virol. 66(5), 2904-2915 (1992).
2. Cai WZ, Schaffer PA: Herpes simplex virus type 1 ICP0 plays a critical role in the de novo synthesis of infectious virus following transfection of viral DNA. J. Virol. 63(11), 4579-4589 (1989). (Pubitemid 19257832)
3. Everett RD: Construction and characterization of herpes simplex virus type 1 mutants with defined lesions in immediate early gene 1. J. Gen. Virol. 70(Pt 5), 1185-1202 (1989). (Pubitemid 19131627)
4. Sacks WR, Schaffer PA: Deletion mutants in the gene encoding the herpes simplex virus type 1 immediate-early protein ICP0 exhibit impaired growth in cell culture. J. Virol. 61(3), 829-839 (1987). (Pubitemid 17040212)
5. Stow ND, Stow EC: Isolation and characterization of a herpes simplex virus type 1 mutant containing a deletion within the gene encoding the immediate early polypeptide Vmw110. J. Gen. Virol. 67(Pt 12), 2571-2585 (1986). (Pubitemid 17197588)
6. Cai W, Astor TL, Liptak LM, Cho C, Coen DM, Schaffer PA: The herpes simplex virus type 1 regulatory protein ICP0 enhances virus replication during acute infection and reactivation from latency. J. Virol. 67(12), 7501-7512 (1993). (Pubitemid 23343880)
7. Halford WP, Schaffer PA: Optimized viral dose and transient immunosuppression enable herpes simplex virus ICP0-null mutants to establish wild-type levels of latency in vivo. J. Virol. 74(13), 5957-5967 (2000). (Pubitemid 30412965)
8. Leib DA, Coen DM, Bogard CL et al.: Immediate-early regulatory gene mutants define different stages in the establishment and reactivation of herpes simplex virus latency. J. Virol. 63(2), 759-768 (1989). (Pubitemid 19057243)
9. Halford WP, Schaffer PA: ICP0 is required for efficient reactivation of herpes simplex virus type 1 from neuronal latency. J. Virol. 75(7), 3240-3249 (2001). (Pubitemid 32225887)
10. Everett RD: Trans activation of transcription by herpes virus products: requirement for two HSV-1 immediate-early polypeptides for maximum activity. EMBO J. 3(13), 3135-3141 (1984).
11. Gelman IH, Silverstein S: Identification of immediate early genes from herpes simplex virus that transactivate the virus thymidine kinase gene. Proc. Natl Acad. Sci. USA 82(16), 5265-5269 (1985). (Pubitemid 15012087)
12. O'Hare P, Hayward GS: Three trans-acting regulatory proteins of herpes simplex virus modulate immediate-early gene expression in a pathway involving positive and negative feedback regulation. J. Virol. 56(3), 723-733 (1985). (Pubitemid 16211808)
13. Perry LJ, Rixon FJ, Everett RD, Frame MC, McGeoch DJ: Characterization of the IE110 gene of herpes simplex virus type 1. J. Gen. Virol. 67(Pt 11), 2365-2380 (1986). (Pubitemid 17179529)
14. Quinlan MP, Knipe DM: Stimulation of expression of a herpes simplex virus DNA-binding protein by two viral functions. Mol. Cell. Biol. 5(5), 957-963 (1985). (Pubitemid 15110283)
15. Everett RD, Maul GG: HSV-1 IE protein Vmw110 causes redistribution of PML. EMBO J. 13(21), 5062-5069 (1994). (Pubitemid 24341087)
16. Maul GG, Everett RD: The nuclear location of PML, a cellular member of the C3HC4 zinc-binding domain protein family, is rearranged during herpes simplex virus infection by the C3HC4 viral protein ICP0. J. Gen. Virol. 75(Pt 6), 1223-1233 (1994). (Pubitemid 24174037)
17. Chen J, Panagiotidis C, Silverstein S: Multimerization of ICP0, a herpes simplex virus immediate-early protein. J. Virol. 66(9), 5598-5602 (1992).
18. Ciufo DM, Mullen MA, Hayward GS: Identification of a dimerization domain in the C-terminal segment of the IE110 transactivator protein from herpes simplex virus. J. Virol. 68(5), 3267-3282 (1994). (Pubitemid 24129776)
19. Everett RD, Meredith M, Orr A: The ability of herpes simplex virus type 1 immediate-early protein Vmw110 to bind to a ubiquitin-specific protease contributes to its roles in the activation of gene expression and stimulation of virus replication. J. Virol. 73(1), 417-426 (1999). (Pubitemid 28565386)
20. Barlow PN, Luisi B, Milner A, Elliott M, Everett R: Structure of the C3HC4 domain by 1H-nuclear magnetic resonance spectroscopy. A new structural class of zinc-finger. J. Mol. Biol. 237(2), 201-211 (1994).
21. Everett RD, Barlow P, Milner A et al.: A novel arrangement of zinc-binding residues and secondary structure in the C3HC4 motif of an alpha herpes virus protein family. J. Mol. Biol. 234(4), 1038-1047 (1993). (Pubitemid 24027234)
22. Everett RD: A detailed mutational analysis of Vmw110, a trans-acting transcriptional activator encoded by herpes simplex virus type 1. EMBO J. 6(7), 2069-2076 (1987).
23. Everett R, O'Hare P, O'Rourke D, Barlow P, Orr A: Point mutations in the herpes simplex virus type 1 Vmw110 RING finger helix affect activation of gene expression, viral growth, and interaction with PML-containing nuclear structures. J. Virol. 69(11), 7339-7344 (1995).
24. Lium EK, Silverstein S: Mutational analysis of the herpes simplex virus type 1 ICP0 C3HC4 zinc ring finger reveals a requirement for ICP0 in the expression of the essential a27 gene. J. Virol. 71(11), 8602-8614 (1997). (Pubitemid 27446442)
25. O'Rourke D, Elliott G, Papworth M, Everett R, O'Hare P: Examination of determinants for intranuclear localization and transactivation within the RING finger of herpes simplex virus type 1 IE110k protein. J. Gen. Virol. 79(Pt 3), 537-548 (1998). (Pubitemid 28115877)
26. Harris RA, Everett RD, Zhu XX, Silverstein S, Preston CM: Herpes simplex virus type 1 immediate-early protein Vmw110 reactivates latent herpes simplex virus type 2 in an in vitro latency system. J. Virol. 63(8), 5313-5315 (1989).
27. Everett RD, Meredith M, Orr A, Cross A, Kathoria M, Parkinson J: A novel ubiquitin-specific protease is dynamically associated with the PML nuclear domain and binds to a herpesvirus regulatory protein. EMBO J. 16(7), 1519-1530 (1997). (Pubitemid 27151947)
28. Meredith M, Orr A, Elliott M, Everett R: Separation of sequence requirements for HSV-1 Vmw110 multimerisation and interaction with a 135-kDa cellular protein. Virology 209(1), 174-187 (1995).
29. Meredith M, Orr A, Everett R: Herpes simplex virus type 1 immediate-early protein Vmw110 binds strongly and specifically to a 135-kDa cellular protein. Virology 200(2), 457-469 (1994). (Pubitemid 24146522)
30. Lees-Miller SP, Long MC, Kilvert MA, Lam V, Rice SA, Spencer CA: Attenuation of DNA-dependent protein kinase activity and its catalytic subunit by the herpes simplex virus type 1 transactivator ICP0. J. Virol. 70(11), 7471-7477 (1996). (Pubitemid 26339051)
31. Parkinson J, Lees-Miller SP, Everett RD: Herpes simplex virus type 1 immediate-early protein vmw110 induces the proteasome-dependent degradation of the catalytic subunit of DNA-dependent protein kinase. J. Virol. 73(1), 650-657 (1999). (Pubitemid 28565409)
32. Chelbi-Alix MK, de The H: Herpes virus induced proteasome-dependent degradation of the nuclear bodies-associated PML and Sp100 proteins. Oncogene 18(4), 935-941 (1999). (Pubitemid 29086270)
33. Everett RD, Freemont P, Saitoh H et al.: The disruption of ND10 during herpes simplex virus infection correlates with the Vmw110- and proteasome-dependent loss of several PML isoforms. J. Virol. 72(8), 6581-6591 (1998). (Pubitemid 28323974)
34. Muller S, Dejean A: Viral immediate-early proteins abrogate the modification by SUMO-1 of PML and Sp100 proteins, correlating with nuclear body disruption. J. Virol. 73(6), 5137-5143. (1999). (Pubitemid 29246776)
35. Parkinson J, Everett RD: Alphaherpesvirus proteins related to herpes simplex virus type 1 ICP0 affect cellular structures and proteins. J. Virol. 74(21), 10006-10017 (2000).
36. Everett RD, Earnshaw WC, Findlay J, Lomonte P: Specific destruction of kinetochore protein CENP-C and disruption of cell division by herpes simplex virus immediate-early protein Vmw110. EMBO J. 18(6), 1526-1538 (1999). (Pubitemid 29127066)
37. Lomonte P, Morency E: Centromeric protein CENP-B proteasomal degradation induced by the viral protein ICP0. FEBS Lett. 581(4), 658-662 (2007). (Pubitemid 46223563)
38. Lomonte P, Sullivan KF, Everett RD: Degradation of nucleosome-associated centromeric histone H3-like protein CENP-A induced by herpes simplex virus type 1 protein ICP0. J. Biol. Chem. 276(8), 5829-5835. (2001).
39. Lilley CE, Chaurushiya MS, Boutell C et al.: A viral E3 ligase targets RNF8 and RNF168 to control histone ubiquitination and DNA damage responses. EMBO J. 29(5), 943-955 (2010).
40. Everett RD: ICP0 induces the accumulation of colocalizing conjugated ubiquitin. J. Virol. 74(21), 9994-10005 (2000).
41. Parkinson J, Everett RD: Alphaherpesvirus proteins related to herpes simplex virus type 1 ICP0 induce the formation of colocalizing, conjugated ubiquitin. J. Virol. 75(11), 5357-5362 (2001). (Pubitemid 32448558)
42. Boutell C, Sadis S, Everett RD: Herpes simplex virus type 1 immediate-early protein ICP0 and is isolated RING finger domain act as ubiquitin E3 ligases in vitro. J. Virol. 76(2), 841-850 (2002). (Pubitemid 34033381)
43. Gu H, Roizman B: The degradation of promyelocytic leukemia and Sp100 proteins by herpes simplex virus 1 is mediated by the ubiquitin-conjugating enzyme UbcH5a. Proc. Natl Acad. Sci. USA 100(15), 8963-8968 (2003). (Pubitemid 36899206)
44. Vanni E, Gatherer D, Boutell C: Functional characterisation of RING finger residues required for ICP0's ability to interact with cellular ubiquitin conjugating enzymes. Presented at: 35th International Herpesvirus Workshop. UT, USA, 24-30 July 2010.
45. Diao L, Zhang B, Fan J et al.: Herpes virus proteins ICP0 and BICP0 can activate NF-kB by catalyzing IkBa ubiquitination. Cell Signal. 17(2), 217-229 (2005). (Pubitemid 39371049)
46. Everett RD, Boutell C, McNair C, Grant L, Orr A: Comparison of the biological and biochemical activities of several members of the alphaherpesvirus ICP0 family of proteins. J. Virol. 84(7), 3476-3487 (2010).
47. Hagglund R, Van Sant C, Lopez P, Roizman B: Herpes simplex virus 1-infected cell protein 0 contains two E3 ubiquitin ligase sites specific for different E2 ubiquitin-conjugating enzymes. Proc. Natl Acad. Sci. USA 99(2), 631-636 (2002). (Pubitemid 34106563)
48. Van Sant C, Hagglund R, Lopez P, Roizman B: The infected cell protein 0 of herpes simplex virus 1 dynamically interacts with proteasomes, binds and activates the cdc34 E2 ubiquitin-conjugating enzyme, and possesses in vitro E3 ubiquitin ligase activity. Proc. Natl Acad. Sci. USA 98(15), 8815-8820 (2001). (Pubitemid 32678110)
49. Hagglund R, Roizman B: Herpes simplex virus 1 mutant in which the ICP0 HUL-1 E3 ubiquitin ligase site is disrupted stabilizes cdc34 but degrades d-type cyclins and exhibits diminished neurotoxicity. J. Virol. 77(24), 13194-13202 (2003). (Pubitemid 37494315)
50. Everett RD: Herpes simplex virus type 1 regulatory protein ICP0 does not protect cyclins D1 and D3 from degradation during infection. J. Virol. 78(18), 9599-9604 (2004). (Pubitemid 39187077)
51. Canning M, Boutell C, Parkinson J, Everett RD: A RING finger ubiquitin ligase is protected from autocatalyzed ubiquitination and degradation by binding to ubiquitin-specific protease USP7. J. Biol. Chem. 279(37), 38160-38168 (2004). (Pubitemid 39295962)
52. Boutell C, Canning M, Orr A, Everett RD: Reciprocal activities between herpes simplex virus type 1 regulatory protein ICP0, a ubiquitin E3 ligase, and ubiquitin-specific protease USP7. J. Virol. 79(19), 12342-12354 (2005). (Pubitemid 41346096)
53. Boutell C, Everett RD: The herpes simplex virus type 1 (HSV-1) regulatory protein ICP0 interacts with and ubiquitinates p53. J. Biol. Chem. 278(38), 36596-36602 (2003). (Pubitemid 37139991)
54. Boutell C, Orr A, Everett RD: PML residue lysine 160 is required for the degradation of PML induced by herpes simplex virus type 1 regulatory protein ICP0. J. Virol. 77(16), 8686-8694 (2003). (Pubitemid 36936079)
55. Wilcox KW, Kohn A, Sklyanskaya E, Roizman B: Herpes simplex virus phosphoproteins. I. Phosphate cycles on and off some viral polypeptides and can alter their affinity for DNA. J. Virol. 33(1), 167-182 (1980). (Pubitemid 10157285)
56. Davido DJ, von Zagorski WF, Lane WS, Schaffer PA: Phosphorylation site mutations affect herpes simplex virus type 1 ICP0 function. J. Virol. 79(2), 1232-1243 (2005). (Pubitemid 40053905)
57. Boutell C, Everett R, Hilliard J, Schaffer P, Orr A, Davido D: Herpes simplex virus type 1 ICP0 phosphorylation mutants impair the E3 ubiquitin ligase activity of ICP0 in a cell type-dependent manner. J. Virol. 82(21), 10647-10656 (2008). (Pubitemid 352691194)
58. Everett RD, Chelbi-Alix MK: PML and PML nuclear bodies: implications in antiviral defence. Biochimie 89(6-7), 819-830 (2007). (Pubitemid 47008945)
59. Hagglund R, Roizman B: Role of ICP0 in the strategy of conquest of the host cell by herpes simplex virus 1. J. Virol. 78(5), 2169-2178 (2004). (Pubitemid 38228910)
60. Kummer M, Turza NM, Muhl-Zurbes P et al.: Herpes simplex virus type 1 induces CD83 degradation in mature dendritic cells with immediate-early kinetics via the cellular proteasome. J. Virol. 81(12), 6326-6338 (2007). (Pubitemid 46878039)
61. Mossman KL, Ashkar AA: Herpesviruses and the innate immune response. Viral Immunol. 18(2), 267-281 (2005). (Pubitemid 41106006)
62. Weitzman MD, Lilley CE, Chaurushiya MS. Genomes in conflict: maintaining genome integrity during virus infection. Annu. Rev. Microbiol. 64, 61-81 (2010).
63. Maul GG, Negorev D, Bell P, Ishov AM: Review: properties and assembly mechanisms of ND10, PML bodies, or PODs. J. Struct. Biol. 129(2-3), 278-287 (2000). (Pubitemid 30481369)
64. Maul GG, Ishov AM, Everett RD. Nuclear domain 10 as preexisting potential replication start sites of herpes simplex virus type-1. Virology 217(1), 67-75 (1996). (Pubitemid 26103599)
65. Everett RD, Murray J: ND10 components relocate to sites associated with herpes simplex virus type 1 nucleoprotein complexes during virus infection. J. Virol. 79(8), 5078-5089 (2005). (Pubitemid 40464258)
66. Ishov AM, Sotnikov AG, Negorev D et al.: PML is critical for ND10 formation and recruits the PML-interacting protein daxx to this nuclear structure when modified by SUMO-1. J. Cell Biol. 147(2), 221-234 (1999).
67. Ascoli CA, Maul GG: Identification of a novel nuclear domain. J. Cell Biol. 112(5), 785-795 (1991). (Pubitemid 21909627)
68. Ishov AM, Vladimirova OV, Maul GG: Heterochromatin and ND10 are cell-cycle regulated and phosphorylation-dependent alternate nuclear sites of the transcription repressor Daxx and SWI/SNF protein ATRX. J. Cell Sci. 117(Pt 17), 3807-3820 (2004). n Highlights the role of two ND10-associated proteins in HSV-1 replication. (Pubitemid 39207319)
69. Lukashchuk V, Everett RD: Regulation of ICP0-null mutant herpes simplex virus type 1 infection by ND10 components ATRX and hDaxx. J. Virol. 84(8), 4026-4040 (2010).
70. Everett RD, Rechter S, Papior P, Tavalai N, Stamminger T, Orr A: PML contributes to a cellular mechanism of repression of herpes simplex virus type 1 infection that is inactivated by ICP0. J. Virol. 80(16), 7995-8005 (2006). (Pubitemid 44182300)
71. Everett RD, Parada C, Gripon P, Sirma H, Orr A: Replication of ICP0-null mutant herpes simplex virus type 1 is restricted by both PML and Sp100. J. Virol. 82(6), 2661-2672 (2008). (Pubitemid 351329157)
72. Cliffe AR, Knipe DM: Herpes simplex virus ICP0 promotes both histone removal and acetylation on viral DNA during lytic infection. J. Virol. 82(24), 12030-12038 (2008).
73. Coleman HM, Connor V, Cheng ZS, Grey F, Preston CM, Efstathiou S: Histone modifications associated with herpes simplex virus type 1 genomes during quiescence and following ICP0-mediated de-repression. J. Gen. Virol. 89(Pt 1), 68-77 (2008).
74. Lomonte P, Thomas J, Texier P, Caron C, Khochbin S, Epstein AL: Functional interaction between class II histone deacetylases and ICP0 of herpes simplex virus type 1. J. Virol. 78(13), 6744-6757 (2004). (Pubitemid 38781511)
75. Gu H, Roizman B: Herpes simplex virus-infected cell protein 0 blocks the silencing of viral DNA by dissociating histone deacetylases from the CoREST-REST complex. Proc. Natl Acad. Sci. USA 104(43), 17134-17139 (2007). (Pubitemid 350211004)
76. Everett RD, Parsy ML, Orr A: Analysis of the functions of herpes simplex virus type 1 regulatory protein ICP0 that are critical for lytic infection and derepression of quiescent viral genomes. J. Virol. 83(10), 4963-4977 (2009).
77. Everett RD: Depletion of CoREST does not improve the replication of ICP0 null mutant herpes simplex virus type 1. J. Virol. 84(7), 3695-3698 (2010).
78. Du T, Zhou G, Khan S, Gu H, Roizman B: Disruption of HDAC/CoREST/REST repressor by dnREST reduces genome silencing and increases virulence of herpes simplex virus. Proc. Natl Acad. Sci. USA 107(36), 15904-15909 (2010).
79. Li H, Baskaran R, Krisky DM et al.: Chk2 is required for HSV-1 ICP0-mediated G2/M arrest and enhancement of virus growth. Virology 375(1), 13-23 (2008).
80. Halford WP, Weisend C, Grace J et al.: ICP0 antagonizes Stat 1-dependent repression of herpes simplex virus: implications for the regulation of viral latency. Virol. J. 3, 44 (2006).
81. Leib DA, Harrison TE, Laslo KM, Machalek MA, Moorman NJ, Virgin HW: Interferons regulate the phenotype of wild-type and mutant herpes simplex viruses in vivo. J. Exp. Med. 189(4), 663-672 (1999). (Pubitemid 29193367)
82. Eidson KM, Hobbs WE, Manning BJ, Carlson P, DeLuca NA: Expression of herpes simplex virus ICP0 inhibits the induction of interferon-stimulated genes by viral infection. J. Virol. 76(5), 2180-2191 (2002). (Pubitemid 34150685)
83. Paladino P, Collins SE, Mossman KL: Cellular localization of the herpes simplex virus ICP0 protein dictates its ability to block IRF3-mediated innate immune responses. PLoS ONE 5(4), E10428 (2010).
84. Melroe GT, DeLuca NA, Knipe DM: Herpes simplex virus 1 has multiple mechanisms for blocking virus-induced interferon production. J. Virol. 78(16), 8411-8420 (2004). (Pubitemid 39025107)
85. van Lint AL, Murawski MR, Goodbody RE et al.: Herpes simplex virus immediate-early ICP0 protein inhibits Toll-like receptor 2-dependent inflammatory responses and NF-kappaB signaling. J. Virol. 84(20), 10802-10811 (2010).
86. Daubeuf S, Singh D, Tan Y et al.: HSV ICP0 recruits USP7 to modulate TLR-mediated innate response. Blood 113(14), 3264-3275 (2009).
87. Harle P, Sainz B Jr, Carr DJ, Halford WP: The immediate-early protein, ICP0, is essential for the resistance of herpes simplex virus to interferon-a/b. Virology 293(2), 295-304 (2002).
88. Mossman KL, Saffran HA, Smiley JR: Herpes simplex virus ICP0 mutants are hypersensitive to interferon. J. Virol. 74(4), 2052-2056 (2000). (Pubitemid 30434066)
89. Everett RD, Orr A: Herpes simplex virus type 1 regulatory protein ICP0 aids infection in cells with a preinduced interferon response but does not impede interferon-induced gene induction. J. Virol. 83(10), 4978-4983 (2009).
90. Chee AV, Lopez P, Pandolfi PP, Roizman B: Promyelocytic leukemia protein mediates interferon-based anti-herpes simplex virus 1 effects. J. Virol. 77(12), 7101-7105 (2003). (Pubitemid 36666903)
91. Everett RD, Young DF, Randall RE, Orr A: STAT-1- and IRF-3-dependent pathways are not essential for repression of ICP0-null mutant herpes simplex virus type 1 in human fibroblasts. J. Virol. 82(17), 8871-8881 (2008).